We are currently in the process of obtaining approval for adult and pediatric clinical trials investigating a personalized form of rTMS treatment in a number of disease states. 

Our goal is to determine whether PrTMS could represent a novel therapy that is more effective and far safer than either traditional drug or TMS approaches in the treatment of an array of neurocognitive disorders. We anticipate that  personalized rTMS, which utilizes treatment intensities that are far lower than what standard TMS technique calls for, will result in even fewer rTMS-related side effects and may be able to create a much more robust and lasting synchronization effect compared to traditional rTMS.